Document is current
Any future updates will be listed below
-
Authors
Peng, Jianfeng
Zhang, Lemeng
Wang, Liping
Feng, Hui
Yao, Dongmei
Meng, Rui
Liu, Xiaomei
Li, Xiaohua
Liu, Ningbo
Tan, Bingxu
Huang, Zhaoqin
Li, Shanshan
Meng, Xiangjiao
-
Funding
Funding for this research was provided by:
Bethune·Cancer Radiotherapy Translational Medicine Research Fund (flzh202107)
National Natural Science Foundation of China (81972796 and 82272845)
Key Research and Development Program of Shandong (2021SFGC0501)
- License Information
-
More Information
Article History
Received: 15 April 2023
Accepted: 22 June 2023
First Online: 4 July 2023
Declarations
:
: This study has been approved by the Ethics Review Board of Shandong Cancer Hospital Affiliated to Shandong First Medical University and other sub-centers (No. SDTHEC 2022003004, March 2, 2022), and is in accordance with the provisions of the Declaration of Helsinki. Due to the retrospective design, no separate informed consent was obtained.
: The authors declare that they have no competing interests.
